Clinical Trials Directory

Trials / Completed

CompletedNCT04767685

The Bern Perioperative Biobank

The Bern Perioperative Biobank to Define Perioperative Changes of Molecular Markers of Perioperative Organo-dysfunctions, Inflammation, Adverse Events and Disease Progression

Status
Completed
Phase
Study type
Observational
Enrollment
547 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of the research is to define clinically relevant molecular markers for increased risk of peri-/ postoperative organo-dysfunctions, inflammation, adverse events and disease progression. To better understand the perioperative impact the investigators aim to determine perioperative levels of molecular markers over time in the available samples and clinical data of the Bern perioperative Biobank (BPBB) cohort to finally increase quality of perioperative care of patients by permitting preventive measures to be taken early in patients at risk.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2021-02-23
Last updated
2022-11-15

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04767685. Inclusion in this directory is not an endorsement.

The Bern Perioperative Biobank (NCT04767685) · Clinical Trials Directory